Clinical Trial Update: Shenbai Granules for Preventing Malignant Transformation of High-risk Colorectal Adenomas [NA]

View source ↗

Summary

An update on a clinical trial evaluating Shenbai Granules to prevent malignant transformation of high-risk colorectal adenomas; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenoma
• Colorectal Neoplasms

Drugs mentioned

• Shenbai Granules

Snippet

Sponsor: Jiangsu Famous Medical Technology Co., Ltd. | Conditions: Colorectal Adenoma, High Risk | NA | Status: NOT_YET_RECRUITING